1
|
Ma S, Wei C, Bao Y, Liu Y, Jiang H, Tong W, Chen D, Huang X. Modular coupling MOF nanozyme with natural enzyme on hollow fiber membrane for rapid and reusable detection of H 2O 2 and glucose. Mikrochim Acta 2024; 191:107. [PMID: 38240908 DOI: 10.1007/s00604-023-06150-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Accepted: 12/11/2023] [Indexed: 01/23/2024]
Abstract
A novel strategy based on gradient porous hollow fiber membrane (GPF) is proposed for the modular assembly of enzyme-nanozyme cascade systems. The porous structure of GPF provided sufficient specific surface area, while the gradient structure effectively minimized the leaching of enzymes and nanozymes. To enhance stability, we prepared and immobilized metal-organic framework (MOF) nanozymes, resulting in the fabrication of GPF-MOF with excellent stability and reusability for colorimetric H2O2 detection. To improve specificity and expand the detection range, micro-crosslinked natural enzymes were modularly assembled, using glucose oxidase as the model enzyme. The assembled system, GPF-mGOx@MOF, achieved a low detection limit of 0.009 mM and a linear range of 0.2 to 11 mM. The sensor retained 87.2% and 80.7% of initial activity after being stored for 49 days and 9 recycles, respectively. Additionally, the reliability of the biosensor was validated through glucose determination of human blood and urine samples, yielding comparable results to a commercial glucose meter.
Collapse
Affiliation(s)
- Shuyan Ma
- Key Laboratory of Macromolecular Synthesis and Functionalization (MOE), ERC of Membrane and Water Treatment (MOE), Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China
| | - Chenjie Wei
- Key Laboratory of Macromolecular Synthesis and Functionalization (MOE), ERC of Membrane and Water Treatment (MOE), Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
| | - Yuheng Bao
- Key Laboratory of Macromolecular Synthesis and Functionalization (MOE), ERC of Membrane and Water Treatment (MOE), Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China
| | - Yanhui Liu
- College of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, China
| | - Hong Jiang
- Kidney Disease Center, College of Medicine, the First Affiliated Hospital, Zhejiang University, Hangzhou, 310003, China
| | - Weijun Tong
- Key Laboratory of Macromolecular Synthesis and Functionalization (MOE), ERC of Membrane and Water Treatment (MOE), Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China
| | - Dajing Chen
- College of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, China.
| | - Xiaojun Huang
- Key Laboratory of Macromolecular Synthesis and Functionalization (MOE), ERC of Membrane and Water Treatment (MOE), Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
| |
Collapse
|
2
|
Suwannasom N, Sriaksorn N, Thepmalee C, Khoothiam K, Prapan A, Bäumler H, Thephinlap C. Curcumin-loaded albumin submicron particles with potential as a cancer therapy: an in vitro study. BEILSTEIN JOURNAL OF NANOTECHNOLOGY 2023; 14:1127-1140. [PMID: 38034473 PMCID: PMC10682534 DOI: 10.3762/bjnano.14.93] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 10/24/2023] [Indexed: 12/02/2023]
Abstract
Curcumin (CUR), a polyphenolic compound, shows promising biological properties, particularly antioxidant activity. However, its medical applications are limited due to its low water solubility, bioavailability, and pH-instability. CUR-loaded albumin microparticles (CUR-HSA-MPs) of submicron size in the range of 800 to 900 nm and a zeta potential of -15 mV were prepared. The CUR loading efficiency was up to 65%. A maximum release of 37% of the encapsulated CUR was observed within 6 h when the CUR-HSA-MPs were dispersed in 50% ethanol in PBS at pH 7, while in RPMI 1640 medium the release was 7%. This demonstrates a sustainable release. The in vitro cytotoxicity of CUR-HSA-MPs showed promising anticancer potential against human hepatocellular carcinoma (Huh-7) and human breast adenocarcinoma (MCF-7) cell lines, although this effect was less pronounced in human dermal fibroblasts (HDFB) and human cholangiocyte (MMN) cell lines. Confocal microscopy was used to confirm the uptake of CUR-HSA-MPs by cancer cells. Our studies revealed that HSA-MPs are potentially promising vehicles for increasing the solubility and bioavailability of CUR.
Collapse
Affiliation(s)
- Nittiya Suwannasom
- Division of Biochemistry, School of Medical Sciences, University of Phayao 56000, Thailand
| | - Netsai Sriaksorn
- Division of Biochemistry, School of Medical Sciences, University of Phayao 56000, Thailand
| | - Chutamas Thepmalee
- Division of Biochemistry, School of Medical Sciences, University of Phayao 56000, Thailand
| | - Krissana Khoothiam
- Department of Radiological Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand
| | - Ausanai Prapan
- Division of Microbiology, School of Medical Sciences, University of Phayao 56000, Thailand
| | - Hans Bäumler
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Chonthida Thephinlap
- Division of Biochemistry, School of Medical Sciences, University of Phayao 56000, Thailand
| |
Collapse
|
3
|
Li Y, Huang Y, Zhu K, Duan X, Li S, Xu M, Yang C, Liu J, Bäumler H, Yu P, Xie H, Li B, Cao Y, Chen L. Functionalized protein microparticles targeting hACE2 as a novel preventive strategy for SARS-CoV-2 infection. Int J Pharm 2023; 638:122921. [PMID: 37028575 PMCID: PMC10082558 DOI: 10.1016/j.ijpharm.2023.122921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2022] [Revised: 03/03/2023] [Accepted: 03/31/2023] [Indexed: 04/08/2023]
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), resulting in a serious burden on public health and social economy worldwide. SARS-CoV-2 infection is mainly initialized in the nasopharyngeal cavity through the binding of viral spike (S) protein to human angiotensin-converting enzyme 2 (hACE2) receptors which are widely expressed in many human cells. Thus, blockade of the interaction between viral S protein and hACE2 receptor in the primary entry site is a promising prevention strategy for the management of COVID-19. Here we showed protein microparticles (PMPs) decorated with hACE2 could bind and neutralize SARS-CoV-2 S protein-expressing pseudovirus (PSV) and protect host cells from infection in vitro. In the hACE2 transgenic mouse model, administration of intranasal spray with hACE2-decorated PMPs markedly decreased the viral load of SARS-CoV-2 in the lungs though the inflammation was not attenuated significantly. Our results provided evidence for developing functionalized PMPs as a potential strategy for preventing emerging air-borne infectious pathogens, such as SARS-CoV-2 infection.
Collapse
|
4
|
Steffen A, Xiong Y, Georgieva R, Kalus U, Bäumler H. Bacterial safety study of the production process of hemoglobin-based oxygen carriers. BEILSTEIN JOURNAL OF NANOTECHNOLOGY 2022; 13:114-126. [PMID: 35145832 PMCID: PMC8805039 DOI: 10.3762/bjnano.13.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Accepted: 01/07/2022] [Indexed: 06/14/2023]
Abstract
Hemoglobin microparticles (HbMP) produced with a three-step procedure, including coprecipitation of hemoglobin with manganese carbonate, protein cross-linking, and dissolution of the carbonate template were shown to be suitable for application as artificial oxygen carriers. First preclinical safety investigations delivered promising results. Bacterial safety plays a decisive role during the production of HbMP. Therefore, the bioburden and endotoxin content of the starting materials (especially hemoglobin) and the final particle suspension are intensively tested. However, some bacteria may not be detected by standard tests due to low concentration. The aim of this study was to investigate how these bacteria would behave in the fabrication process. Biocidal effects are known for glutaraldehyde and for ethylenediaminetetraacetic acid, chemicals that are used in the fabrication process of HbMP. It was shown that both chemicals prevent bacterial growth at the concentrations used during HbMP fabrication. In addition, the particle production was carried out with hemoglobin solutions spiked with Escherichia coli or Staphylococcus epidermidis. No living bacteria could be detected in the final particle suspensions. Therefore, we conclude that the HbMP fabrication procedure is safe in respect of bacterial contamination.
Collapse
Affiliation(s)
- Axel Steffen
- Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Yu Xiong
- Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Radostina Georgieva
- Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany
- Department of Medical Physics, Biophysics and Radiology, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria
| | - Ulrich Kalus
- Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Hans Bäumler
- Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany
| |
Collapse
|
5
|
Vikulina AS, Campbell J. Biopolymer-Based Multilayer Capsules and Beads Made via Templating: Advantages, Hurdles and Perspectives. NANOMATERIALS (BASEL, SWITZERLAND) 2021; 11:2502. [PMID: 34684943 PMCID: PMC8537085 DOI: 10.3390/nano11102502] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 09/14/2021] [Accepted: 09/20/2021] [Indexed: 12/12/2022]
Abstract
One of the undeniable trends in modern bioengineering and nanotechnology is the use of various biomolecules, primarily of a polymeric nature, for the design and formulation of novel functional materials for controlled and targeted drug delivery, bioimaging and theranostics, tissue engineering, and other bioapplications. Biocompatibility, biodegradability, the possibility of replicating natural cellular microenvironments, and the minimal toxicity typical of biogenic polymers are features that have secured a growing interest in them as the building blocks for biomaterials of the fourth generation. Many recent studies showed the promise of the hard-templating approach for the fabrication of nano- and microparticles utilizing biopolymers. This review covers these studies, bringing together up-to-date knowledge on biopolymer-based multilayer capsules and beads, critically assessing the progress made in this field of research, and outlining the current challenges and perspectives of these architectures. According to the classification of the templates, the review sequentially considers biopolymer structures templated on non-porous particles, porous particles, and crystal drugs. Opportunities for the functionalization of biopolymer-based capsules to tailor them toward specific bioapplications is highlighted in a separate section.
Collapse
Affiliation(s)
- Anna S. Vikulina
- Department of Theory and Bio-Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg, 1, 14476 Potsdam, Germany
- Bavarian Polymer Institute, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Dr.-Mack-Straße, 77, 90762 Fürth, Germany
| | - Jack Campbell
- School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK;
| |
Collapse
|
6
|
Sikkema R, Keohan B, Zhitomirsky I. Hyaluronic-Acid-Based Organic-Inorganic Composites for Biomedical Applications. MATERIALS (BASEL, SWITZERLAND) 2021; 14:4982. [PMID: 34501070 PMCID: PMC8434239 DOI: 10.3390/ma14174982] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 08/23/2021] [Accepted: 08/27/2021] [Indexed: 01/22/2023]
Abstract
Applications of natural hyaluronic acid (HYH) for the fabrication of organic-inorganic composites for biomedical applications are described. Such composites combine unique functional properties of HYH with functional properties of hydroxyapatite, various bioceramics, bioglass, biocements, metal nanoparticles, and quantum dots. Functional properties of advanced composite gels, scaffold materials, cements, particles, films, and coatings are described. Benefiting from the synergy of properties of HYH and inorganic components, advanced composites provide a platform for the development of new drug delivery materials. Many advanced properties of composites are attributed to the ability of HYH to promote biomineralization. Properties of HYH are a key factor for the development of colloidal and electrochemical methods for the fabrication of films and protective coatings for surface modification of biomedical implants and the development of advanced biosensors. Overcoming limitations of traditional materials, HYH is used as a biocompatible capping, dispersing, and structure-directing agent for the synthesis of functional inorganic materials and composites. Gel-forming properties of HYH enable a facile and straightforward approach to the fabrication of antimicrobial materials in different forms. Of particular interest are applications of HYH for the fabrication of biosensors. This review summarizes manufacturing strategies and mechanisms and outlines future trends in the development of functional biocomposites.
Collapse
Affiliation(s)
| | | | - Igor Zhitomirsky
- Department of Materials Science and Engineering, McMaster University, Hamilton, ON L8S4L7, Canada; (R.S.); (B.K.)
| |
Collapse
|
7
|
Fabrication and Characterization of Human Serum Albumin Particles Loaded with Non-Sericin Extract Obtained from Silk Cocoon as a Carrier System for Hydrophobic Substances. Polymers (Basel) 2021; 13:polym13030334. [PMID: 33494401 PMCID: PMC7865381 DOI: 10.3390/polym13030334] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Revised: 01/14/2021] [Accepted: 01/16/2021] [Indexed: 01/06/2023] Open
Abstract
Non-sericin (NS) extract was produced from the ethanolic extract of Bombyx mori silk cocoons. This extract is composed of both carotenoids and flavonoids. Many of these compounds are composed of substances of poor aqueous solubility. Thus, this study focused on the development of a carrier system created from biocompatible and biodegradable materials to improve the biological activity of NS extracts. Accordingly, NS was incorporated into human serum albumin template particles with MnCO3 (NS-HSA MPs) by loading NS into the preformed HAS-MnCO3 microparticles using the coprecipitation crosslinking dissolution technique (CCD-technique). After crosslinking and template dissolution steps, the NS loaded HSA particles are negatively charged, have a size ranging from 0.8 to 0.9 µm, and are peanut shaped. The degree of encapsulation efficiency ranged from 7% to 57% depending on the initial NS concentration and the steps of adsorption. In addition, NS-HSA MPs were taken up by human lung adenocarcinoma (A549 cell) for 24 h. The promotion of cellular uptake was evaluated by flow cytometry and the results produced 99% fluorescent stained cells. Moreover, the results from CLSM and 3D fluorescence imaging confirmed particle localization in the cells. Interestingly, NS-HSA MPs could not induce inflammation through nitric oxide production from macrophage RAW264.7 cells. This is the first study involving the loading of non-sericin extracts into HSA MPs by CCD technique to enhance the bioavailability and biological effects of NS. Therefore, HSA MPs could be utilized as a carrier system for hydrophobic substances targeting cells with albumin receptors.
Collapse
|
8
|
Kaewprayoon W, Suwannasom N, Kloypan C, Steffen A, Xiong Y, Schellenberger E, Pruß A, Georgieva R, Bäumler H. Determination of Methemoglobin in Hemoglobin Submicron Particles Using NMR Relaxometry. Int J Mol Sci 2020; 21:ijms21238978. [PMID: 33256027 PMCID: PMC7730817 DOI: 10.3390/ijms21238978] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 11/23/2020] [Accepted: 11/23/2020] [Indexed: 01/24/2023] Open
Abstract
Methemoglobin (MetHb) is a hemoglobin (Hb) derivative with the heme iron in ferric state (Fe3+), unable to deliver oxygen. Quantification of methemoglobin is a very important diagnostic parameter in hypoxia. Recently, novel hemoglobin microparticles (Hb-MP) with a narrow size distribution around 700 nm, consisting of cross-linked Hb were proposed as artificial oxygen carriers. The cross-linking of Hb by glutaraldehyde (GA) generates a certain amount of MetHb. Due to the strong light scattering, quantitative determination of MetHb in Hb-MP suspensions by common spectrophotometry is not possible. Here, we demonstrate that 1H2O NMR relaxometry is a perfect tool for direct measurement of total Hb and MetHb concentrations in Hb-MP samples. The longitudinal relaxation rate 1/T1 shows a linear increase with increasing MetHb concentration, whereas the transverse relaxation rate 1/T2 linearly increases with the total Hb concentration. In both linear regressions the determination coefficient (R2) is higher than 0.99. The method does not require time-consuming pretreatment or digestion of the particles and is not impaired by light scattering. Therefore, it can be established as the method of choice for the quality control of Hb-MP and similar hemoglobin-based oxygen carriers in the future.
Collapse
Affiliation(s)
- Waraporn Kaewprayoon
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
- Department of Pharmacy, Payap University, Chiang Mai 50000, Thailand
| | - Nittiya Suwannasom
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
- Division of Biochemistry and Nutrition, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand
| | - Chiraphat Kloypan
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
- Division of Clinical Immunology and Transfusion Sciences, School of Allied Health Sciences, University of Phayao, Phayao 56000, Thailand
| | - Axel Steffen
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
| | - Yu Xiong
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
| | - Eyk Schellenberger
- Charité-Universitätsmedizin Berlin, Institute of Radiology and Children Radiology, 10117 Berlin, Germany;
| | - Axel Pruß
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
| | - Radostina Georgieva
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
- Department of Medical Physics, Biophysics and Radiology, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria
| | - Hans Bäumler
- Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; (W.K.); (N.S.); (C.K.); (A.S.); (Y.X.); (A.P.); (R.G.)
- Correspondence: ; Tel.: +49-(30)-45052-5131
| |
Collapse
|
9
|
Bäumler H. Künstliche Sauerstofftransporter können mehr als Sauerstoff liefern. TRANSFUSIONSMEDIZIN 2020. [DOI: 10.1055/a-1119-1796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
ZusammenfassungZum gegenwärtigen Zeitpunkt ist in der EU und den USA kein artifizieller Sauerstofftransporter zugelassen. Hämoglobin-basierte Sauerstoff-Carrier (HBOC) sind bereits seit Jahrzehnten Gegenstand wissenschaftlicher Untersuchungen. Ein wesentliches Hindernis bei der Zulassung war bisher der Anspruch der Entwickler, einen universell einsetzbaren Blutersatz zu produzieren. Die Beschränkung auf eine Indikation scheint erfolgversprechender zu sein. Der Ansatz, nicht nur Sauerstoff von der Lunge zum Gewebe, sondern auch der Abtransport von Kohlendioxid vom Gewebe zur Lunge zu transportieren, der effektiver als mit Erythrozyten durchgeführt werden kann, erscheint besonders attraktiv. Aufgrund vielversprechender präklinischer sowie klinischer Untersuchungen besteht die Hoffnung, dass in absehbarer Zeit auch in der EU künstliche Sauerstofftransporter für therapeutische Zwecke zur Verfügung stehen werden.
Collapse
Affiliation(s)
- Hans Bäumler
- Institut für Transfusionsmedizin, Charité – Universitätsmedizin Berlin, Berlin
| |
Collapse
|
10
|
Chaiwaree S, Prapan A, Suwannasom N, Laporte T, Neumann T, Pruß A, Georgieva R, Bäumler H. Doxorubicin-Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake. Pharmaceutics 2020; 12:pharmaceutics12030224. [PMID: 32131545 PMCID: PMC7150780 DOI: 10.3390/pharmaceutics12030224] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Revised: 02/28/2020] [Accepted: 02/28/2020] [Indexed: 12/16/2022] Open
Abstract
Doxorubicin (DOX) is an effective anthracycline antibiotic drug which is commonly used in a broad range cancer therapy. However, due to dose depending side effects and toxicity to non-cancerous tissues, its clinical applications are restricted. To overcome these limitations, human serum albumin (HSA) has been investigated as a biocompatible drug delivery vehicle. In this study, human serum albumin submicron particles (HSA-MPs) were fabricated by using the Co-precipitation–Crosslinking–Dissolution technique (CCD technique) and DOX was loaded into the protein particles by absorption. DOX-HSA-MPs showed uniform peanut-like shape, submicron size and negative zeta-potential (−13 mV). The DOX entrapment efficiency was 25% of the initial amount. The in vitro release in phosphate buffered saline pH 7.4 was less than 1% within 5 h. In contrast, up to 40% of the entrapped DOX was released in presence of a protein digesting enzyme mixture (Pronase®) within the same time. In addition, in vitro cytotoxicity and cellular uptake of DOX-HSA-MPs were evaluated using the lung carcinoma cell line A549. The results demonstrated that DOX-HSA-MPs reduced the cell metabolic activities after 72 h. Interestingly, DOX-HSA-MPs were taken up by A549 cells up to 98% and localized in the cell lysosomal compartment. This study suggests that DOX-HSA-MPs which was fabricated by CCD technique is seen as a promising biopolymer particle as well as a viable alternative for drug delivery application to use for cancer therapy.
Collapse
Affiliation(s)
- Saranya Chaiwaree
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Payap University, Chiang Mai 50000, Thailand
| | - Ausanai Prapan
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
- Department of Radiological Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand
| | - Nittiya Suwannasom
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
- Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand
| | - Tomás Laporte
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
- Instituto de Nanosistemas, Universidad Nacional de San Martín, San Martín, Pcia de Buenos Aires 1021, Argentina
| | - Tanja Neumann
- JPK BioAFM Business, Nano Surfaces Division, Bruker Nano GmbH, 12489 Berlin, Germany;
| | - Axel Pruß
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
| | - Radostina Georgieva
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
- Department of Medical Physics, Biophysics and Radiology, Medical Faculty, Trakia University, 6000 Stara Zagora, Bulgaria
| | - Hans Bäumler
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; (S.C.); (A.P.); (N.S.); (T.L.); (A.P.); (R.G.)
- Correspondence: ; Tel.: +49-30-450525131
| |
Collapse
|
11
|
Kloypan C, Suwannasom N, Chaiwaree S, Prapan A, Smuda K, Baisaeng N, Pruß A, Georgieva R, Bäumler H. In-vitro haemocompatibility of dextran-protein submicron particles. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2019; 47:241-249. [PMID: 30663396 DOI: 10.1080/21691401.2018.1548476] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Blood compatibility is a key requirement to fulfil for intravenous administration of drug and oxygen carrier system. Recently, we published the fabrication of oxidised-dextran (Odex)-crosslinked protein particles by one-pot formulation. In the current study we investigate the haemocompatibility of these Odex - particles including albumin particles (Odex-APs) and haemoglobin particles (Odex-HbMPs). Odex-APs and Odex-HbMPs have a submicron size ranged 800-1000 nm with peanut-like shape and a negative surface charge. In vitro haemocompatibility assays included haemolysis test, indirect phagocytosis test and platelet activation test in human blood. Odex-APs and Odex-HbMPs did not provoke any undesirable effects on the blood cells. Firstly, the ratio of haemolysis after contacted with Odex-crosslinked protein particles were less than 5% and therefore the particles may be considered non-haemolytic. Secondly, the incubation of leukocyte with Odex-APs/HbMPs did not influence the phagocytosis of leukocyte. We conclude that our particles are not recognized by monocytes or granulocytes. Finally, exposure of Odex-APs/HbMPs to platelets did not cause an activation of platelets. Additionally, Odex-HbMP/AP did not enhance or attenuate agonist-induced platelet activation. We conclude that Odex-crosslinked protein particles exhibit a very good haemocompatibility and represent highly promising carriers for drugs or oxygen.
Collapse
Affiliation(s)
- Chiraphat Kloypan
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany.,b Division of Clinical Immunology and Transfusion Sciences, School of Allied Health Sciences , University of Phayao , Phayao , Thailand
| | - Nittiya Suwannasom
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany.,c Division of Biochemistry and Nutrition, School of Medical Sciences , University of Phayao , Phayao , Thailand
| | - Saranya Chaiwaree
- d Department of Radiological Technology, Faculty of Allied Health Sciences , Naresuan University , Phitsanulok , Thailand
| | - Ausanai Prapan
- e Department of Pharmaceutical Technology, Faculty of Pharmacy , Payap University , Chiang Mai , Thailand
| | - Kathrin Smuda
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany
| | - Nuttakorn Baisaeng
- f Division of Pharmaceutical Sciences, School of Pharmaceutical Sciences , University of Phayao , Phayao , Thailand
| | - Axel Pruß
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany
| | - Radostina Georgieva
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany.,g Department of Medical Physics, Biophysics and Radiology, Faculty of Medicine , Trakia University , Stara Zagora , Bulgaria
| | - Hans Bäumler
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany
| |
Collapse
|
12
|
Suwannasom N, Smuda K, Kloypan C, Kaewprayoon W, Baisaeng N, Prapan A, Chaiwaree S, Georgieva R, Bäumler H. Albumin Submicron Particles with Entrapped Riboflavin-Fabrication and Characterization. NANOMATERIALS (BASEL, SWITZERLAND) 2019; 9:E482. [PMID: 30934597 PMCID: PMC6474188 DOI: 10.3390/nano9030482] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/14/2019] [Revised: 03/15/2019] [Accepted: 03/19/2019] [Indexed: 01/19/2023]
Abstract
Although riboflavin (RF) belongs to the water-soluble vitamins of group B, its solubility is low. Therefore, the application of micro-formulations may help to overcome this limiting factor for the delivery of RF. In this study we immobilized RF in newly developed albumin submicron particles prepared using the Co-precipitation Crosslinking Dissolution technique (CCD-technique) of manganese chloride and sodium carbonate in the presence of human serum albumin (HSA) and RF. The resulting RF containing HSA particles (RF-HSA-MPs) showed a narrow size distribution in the range of 0.9 to 1 μm, uniform peanut-like morphology, and a zeta-potential of -15 mV. In vitro release studies represented biphasic release profiles of RF in a phosphate buffered saline (PBS) pH 7.4 and a cell culture medium (RPMI) 1640 medium over a prolonged period. Hemolysis, platelet activation, and phagocytosis assays revealed a good hemocompatibility of RF-HSA-MPs.
Collapse
Affiliation(s)
- Nittiya Suwannasom
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
| | - Kathrin Smuda
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
| | - Chiraphat Kloypan
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- School of Allied Health Sciences, University of Phayao, Phayao 56000, Thailand.
| | - Waraporn Kaewprayoon
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- Faculty of Pharmacy, Payap University, Chiang Mai 50000, Thailand.
| | - Nuttakorn Baisaeng
- School of Pharmaceutical Sciences, University of Phayao, Phayao 56000, Thailand.
| | - Ausanai Prapan
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
| | - Saranya Chaiwaree
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- Faculty of Pharmacy, Payap University, Chiang Mai 50000, Thailand.
| | - Radostina Georgieva
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- Department of Medical Physics, Biophysics and Radiology, Medical Faculty, Trakia University, 6000 Stara Zagora, Bulgaria.
| | - Hans Bäumler
- Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
| |
Collapse
|
13
|
Li T, Li J, Pang Q, Ma L, Tong W, Gao C. Construction of Microreactors for Cascade Reaction and Their Potential Applications as Antibacterial Agents. ACS APPLIED MATERIALS & INTERFACES 2019; 11:6789-6795. [PMID: 30702277 DOI: 10.1021/acsami.8b20069] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Enzymatic cascade reactions in confined microenvironments play important roles in cellular chemical transformation. They also have important biotechnological and therapeutic applications. Here, enzymatic cascade microreactors (MRs) coupling glucose oxidase (GOx) and hemoglobin (Hb) (GOx-Hb MRs) were successfully fabricated by co-precipitation of GOx and Hb into a MnCO3 template, followed by the assembly of a multilayer film on a template surface, slight cross-linking, and final removal of MnCO3. In the presence of glucose with blood-relevant concentration, the GOx-Hb MRs exhibited a higher cascade reaction activity under mild acidic conditions than that under neutral conditions at physiological temperature. The GOx-Hb MRs effectively consumed glucose to generate HO· at pH = 5, which significantly inhibited bacterial growth and biofilm formation. This kind of enzymatic cascade microreactors might be useful for applications in biomedical fields.
Collapse
Affiliation(s)
- Tong Li
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering , Zhejiang University , Hangzhou 310027 , China
| | - Jiawei Li
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering , Zhejiang University , Hangzhou 310027 , China
| | - Qian Pang
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering , Zhejiang University , Hangzhou 310027 , China
| | - Lie Ma
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering , Zhejiang University , Hangzhou 310027 , China
| | - Weijun Tong
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering , Zhejiang University , Hangzhou 310027 , China
| | - Changyou Gao
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering , Zhejiang University , Hangzhou 310027 , China
| |
Collapse
|
14
|
Kloypan C, Prapan A, Suwannasom N, Chaiwaree S, Kaewprayoon W, Steffen A, Xiong Y, Baisaeng N, Georgieva R, Bäumler H. Improved oxygen storage capacity of haemoglobin submicron particles by one-pot formulation. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2018; 46:S964-S972. [DOI: 10.1080/21691401.2018.1521819] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Chiraphat Kloypan
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Division of Clinical Immunology and Transfusion Sciences, School of Allied Health Sciences, University of Phayao, Phayao, Thailand
| | - Ausanai Prapan
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Department of Radiological Technology, Naresuan University, Phitsanulok, Thailand
| | - Nittiya Suwannasom
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Division of Biochemistry and Nutrition, School of Medical Sciences, University of Phayao, Phayao, Thailand
| | - Saranya Chaiwaree
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Department of Pharmaceutical Technology, Payap University, Chiang Mai, Thailand
| | - Waraporn Kaewprayoon
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Department of Pharmaceutical Technology, Payap University, Chiang Mai, Thailand
| | - Axel Steffen
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Yu Xiong
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Nuttakorn Baisaeng
- Division of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand
| | - Radostina Georgieva
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Department of Medical Physics, Biophysics and Radiology, Trakia University, Stara Zagora, Bulgaria
| | - Hans Bäumler
- Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
15
|
Tan C, Selig MJ, Lee MC, Abbaspourrad A. Encapsulation of copigmented anthocyanins within polysaccharide microcapsules built upon removable CaCO3 templates. Food Hydrocoll 2018. [DOI: 10.1016/j.foodhyd.2018.05.036] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|